Analyze Diet
BMC veterinary research2022; 18(1); 53; doi: 10.1186/s12917-021-03126-y

Osteochondral regeneration of the femoral medial condyle by using a scaffold-free 3D construct of synovial membrane-derived mesenchymal stem cells in horses.

Abstract: Medical interventions for subchondral bone cysts in horses have been extensively studied. This study investigated the regeneration of articular cartilage and subchondral bone with scaffold-free three-dimensional (3D) constructs of equine synovial membrane-derived mesenchymal stem cells (SM-MSCs) isolated from three ponies and expanded until over 1.0 × 10 cells at passage 2 (P2). Results: SM-MSCs were strongly positive for CD11a/CD18, CD44, and major histocompatibility complex (MHC) class I; moderately positive for CD90, CD105, and MHC class II; and negative for CD34 and CD45 on flow cytometry and differentiated into osteogenic, chondrogenic, and adipogenic lineages in the tri-lineage differentiation assay. After culturing SM-MSCs until P3, we prepared a construct (diameter, 6.3 mm; height, 5.0 mm) comprising approximately 1920 spheroids containing 3.0 × 10 cells each. This construct was confirmed to be positive for type I collagen and negative for type II collagen, Alcian blue, and Safranin-O upon histological analysis and was subsequently implanted into an osteochondral defect (diameter, 6.8 mm; depth, 5.0 mm) at the right femoral medial condyle. The contralateral (left femoral) defect served as the control. At 3 and 6 months after surgery, the radiolucent volume (RV, mm) of the defects was calculated based on multiplanar reconstruction of computed tomography (CT) images. Magnetic resonance (MR) images were evaluated using a modified two-dimensional MR observation of cartilage repair tissue (MOCART) grading system, while macroscopic (gross) and microscopic histological characteristics were scored according to the International Cartilage Repair Society (ICRS) scale. Compared to the control sites, the implanted defects showed lower RV percentages, better total MOCART scores, higher average gross scores, and higher average histological scores. Conclusions: Implantation of a scaffold-free 3D-construct of SM-MSCs into an osteochondral defect could regenerate the original structure of the cartilage and subchondral bone over 6 months post-surgery in horses, indicating the potential of this technique in treating equine subchondral bone cysts.
Publication Date: 2022-01-22 PubMed ID: 35065631PubMed Central: PMC8783486DOI: 10.1186/s12917-021-03126-yGoogle Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research investigates the regeneration of joint cartilage and underlying bone in horses, using a scaffold-free 3D structure of equine synovial membrane-derived mesenchymal stem cells. The study demonstrated that this technique could restore the original structure of the cartilage and bone over a six-month post-surgical period, which opens up a potential treatment for equine subchondral bone cysts.

Study Design

  • The study used mesenchymal stem cells (SM-MSCs) derived from the synovial membranes of three ponies. These cells were expanded until they reached a significant count.
  • These SM-MSCs were confirmed to express certain cell surface markers and have the capacity to differentiate into bone, cartilage, and fat cell lineages.
  • A scaffold-free 3D construct was prepared using these stem cells. This construct was confirmed to express type I collagen, which is a major component of the extracellular matrix in various tissues.
  • This structure was then implanted into an osteochondral defect (a joint injury affecting both the cartilage and underlying bone) in the right femoral medial condyle of the horse. The equivalent defect on the left side was left untreated to serve as a control.

Measurements and Results

  • The treatment’s effect was assessed at 3 and 6 months post-surgery through a variety of methods. This included computed tomography (CT) scans, magnetic resonance (MR) imaging, and both macroscopic (visible to the naked eye) and microscopic (requiring magnification) inspection of the tissue.
  • The CT images allowed for the calculation of the volume of the defects, whilst the MR images were evaluated using a specific grading system for cartilage repair assessment.
  • The overall assessment demonstrated that the treated defects showed lower radiolucent volume (indicating denser tissue), better cartilage repair scores, and higher average histological scores when compared to the control sites.

Conclusion

  • The results of this study signify the potential of using a scaffold-free 3D construct of SM-MSCs to regenerate osteochondral defects in horses.
  • This technique could possibly serve as a treatment approach for equine subchondral bone cysts – fluid-filled holes in the subchondral bone under the joint cartilage. This disorder is common in horses and can lead to persistent lameness and potentially end a horse’s competitive career.

Cite This Article

APA
Murata D, Ishikawa S, Sunaga T, Saito Y, Sogawa T, Nakayama K, Hobo S, Hatazoe T. (2022). Osteochondral regeneration of the femoral medial condyle by using a scaffold-free 3D construct of synovial membrane-derived mesenchymal stem cells in horses. BMC Vet Res, 18(1), 53. https://doi.org/10.1186/s12917-021-03126-y

Publication

ISSN: 1746-6148
NlmUniqueID: 101249759
Country: England
Language: English
Volume: 18
Issue: 1
Pages: 53
PII: 53

Researcher Affiliations

Murata, Daiki
  • Department of Veterinary Clinical Science, Joint Faculty of Veterinary Medicine, Kagoshima University, Kagoshima, Japan. daiki_net_official@yahoo.co.jp.
  • Department of Regenerative Medicine and Biomedical Engineering, Center for Regenerative Medicine Research, Faculty of Medicine, Saga University, Saga, Japan. daiki_net_official@yahoo.co.jp.
Ishikawa, Shingo
  • Department of Veterinary Clinical Science, Joint Faculty of Veterinary Medicine, Kagoshima University, Kagoshima, Japan.
  • Division of Veterinary Science, Graduate School of Life and Environmental Biosciences, Osaka Prefecture University, Izumi-Sano, Japan.
Sunaga, Takafumi
  • Veterinary Teaching Hospital, Faculty of Veterinary Medicine, Kagoshima University, Kagoshima, Japan.
  • Department of Veterinary Clinical Sciences, Graduate School of Veterinary Medicine, Hokkaido University, Sapporo, Japan.
Saito, Yasuo
  • Veterinary Teaching Hospital, Faculty of Veterinary Medicine, Kagoshima University, Kagoshima, Japan.
Sogawa, Takeshi
  • Veterinary Teaching Hospital, Faculty of Veterinary Medicine, Kagoshima University, Kagoshima, Japan.
Nakayama, Koichi
  • Department of Regenerative Medicine and Biomedical Engineering, Center for Regenerative Medicine Research, Faculty of Medicine, Saga University, Saga, Japan.
Hobo, Seiji
  • Department of Veterinary Clinical Science, Joint Faculty of Veterinary Medicine, Kagoshima University, Kagoshima, Japan.
Hatazoe, Takashi
  • Department of Veterinary Clinical Science, Joint Faculty of Veterinary Medicine, Kagoshima University, Kagoshima, Japan.

MeSH Terms

  • Animals
  • Bone Cysts / veterinary
  • Cartilage, Articular
  • Femur
  • Horse Diseases
  • Horses
  • Mesenchymal Stem Cells
  • Regeneration
  • Synovial Membrane / cytology
  • Tissue Scaffolds

Conflict of Interest Statement

Koichi Nakayama is a co-founder and shareholder of Cyfuse Biomedical KK. The other authors do not declare any conflict of interest.

References

This article includes 30 references

Citations

This article has been cited 13 times.
  1. Leal Reis I, Lopes B, Sousa P, Sousa AC, Branquinho M, Caseiro AR, Pedrosa SS, Rêma A, Oliveira C, Porto B, Atayde L, Amorim I, Alvites R, Santos JM, Maurício AC. Allogenic Synovia-Derived Mesenchymal Stem Cells for Treatment of Equine Tendinopathies and Desmopathies-Proof of Concept. Animals (Basel) 2023 Apr 11;13(8).
    doi: 10.3390/ani13081312pubmed: 37106875google scholar: lookup
  2. Ciamillo SA, Pownder SL, Potter HG, Stefanovski D, Nixon AJ, Ortved KF. Correlation of Arthroscopic Grading and Optical Coherence Tomography as Markers of Early Repair and Predictors of Later Healing Evident on MRI and Histomorphometric Assessment of Cartilage Defects Implanted with Chondrocytes Overexpressing IGF-I. Cartilage 2023 Jun;14(2):210-219.
    doi: 10.1177/19476035231154508pubmed: 36864720google scholar: lookup
  3. Wang Y, Chen Y, Wei Y. Osteoarthritis animal models for biomaterial-assisted osteochondral regeneration. Biomater Transl 2022;3(4):264-279.
  4. Liu TP, Ha P, Xiao CY, Kim SY, Jensen AR, Easley J, Yao Q, Zhang X. Updates on mesenchymal stem cell therapies for articular cartilage regeneration in large animal models. Front Cell Dev Biol 2022;10:982199.
    doi: 10.3389/fcell.2022.982199pubmed: 36147737google scholar: lookup
  5. Bozhokin MS, Korneva YS, Bozhkova SA, Mikhaylova ER, Marchenko DM, Rakhimov BR, Nashchekina YA, Khotin MG. Modern experimental methods for assessing the effectiveness of tissue-engineered products for hyaline cartilage regeneration. Front Bioeng Biotechnol 2025;13:1595116.
    doi: 10.3389/fbioe.2025.1595116pubmed: 40761544google scholar: lookup
  6. Udomluck N, Park H, Lee JY. Advances in biomaterial-based composite spheroid for articular cartilage regeneration. J Tissue Eng 2025 Jan-Dec;16:20417314251349669.
    doi: 10.1177/20417314251349669pubmed: 40626181google scholar: lookup
  7. Higa K, Murata D, Azuma C, Nishida K, Nakayama K. Promotion of bone-tendon healing after ACL reconstruction using scaffold-free constructs comprising ADSCs produced by a bio-3D printer in rabbit models. J Orthop Translat 2025 May;52:265-275.
    doi: 10.1016/j.jot.2025.03.019pubmed: 40342550google scholar: lookup
  8. Cui M, Sun Y, Zhang X, Yang P, Jiang W. Osteochondral tissue engineering in translational practice: histological assessments and scoring systems. Front Bioeng Biotechnol 2024;12:1434323.
    doi: 10.3389/fbioe.2024.1434323pubmed: 39157444google scholar: lookup
  9. Tang D, Tang W, Chen H, Liu D, Jiao F. Synergistic Effects of Icariin and Extracellular Vesicles Derived from Rabbit Synovial Membrane-Derived Mesenchymal Stem Cells on Osteochondral Repair via the Wnt/β-Catenin Pathway. Anal Cell Pathol (Amst) 2024;2024:1083143.
    doi: 10.1155/2024/1083143pubmed: 38946863google scholar: lookup
  10. Reis IL, Lopes B, Sousa P, Sousa AC, Rêma A, Caseiro AR, Briote I, Rocha AM, Pereira JP, Mendonça CM, Santos JM, Lamas L, Atayde LM, Alvites RD, Maurício AC. Case report: Equine metacarpophalangeal joint partial and full thickness defects treated with allogenic equine synovial membrane mesenchymal stem/stromal cell combined with umbilical cord mesenchymal stem/stromal cell conditioned medium. Front Vet Sci 2024;11:1403174.
    doi: 10.3389/fvets.2024.1403174pubmed: 38840629google scholar: lookup
  11. Pérez-Nogués M, Manso-Díaz G, Spirito M, López-Sanromán J. Treatment Comparison for Medial Femoral Condyle Subchondral Cystic Lesions and Prognosis in Yearling Thoroughbred Racehorse Prospects. Animals (Basel) 2024 Apr 6;14(7).
    doi: 10.3390/ani14071122pubmed: 38612360google scholar: lookup
  12. Campbell TM, Trudel G. Protecting the regenerative environment: selecting the optimal delivery vehicle for cartilage repair-a narrative review. Front Bioeng Biotechnol 2024;12:1283752.
    doi: 10.3389/fbioe.2024.1283752pubmed: 38333081google scholar: lookup
  13. Pérez-Nogués M, López-Sanromán J, Spirito M, Manso-Díaz G. Treatments and Prognosis for Subchondral Cystic Lesions in the Distal Extremities in Thoroughbred Prospect Racehorses. Animals (Basel) 2023 Sep 7;13(18).
    doi: 10.3390/ani13182838pubmed: 37760238google scholar: lookup